Greenville, NC: Sterile Drug Product Development and Manufacturing

Meet the team and tour our Greenville, North Carolina manufacturing facility, which a focus on sterile drug product development and manufacturing.

Download the site capabilities fact sheet for Greenville, NC.

関連する施設紹介

Bend, OR

Bend, OR

Brisbane, AU

Brisbane, AU

Cincinnati, OH

Cincinnati, OH

Ferentino, IT

Ferentino, IT

Florence, SC (East)

Florence, SC (East)

Greenville, NC

Greenville, NC

Groningen, NL

Groningen, NL

High Point, NC

High Point, NC

Manatí, PR

Manatí, PR

Milton Park, UK

Milton Park, UK

Monza, IT

Monza, IT

Princeton, NJ

Princeton, NJ

St. Louis, MO

St. Louis, MO

Swindon, UK

Swindon, UK

Tilburg, NL

Tilburg, NL

Toronto, ON

Toronto, ON

Whitby, ON

Whitby, ON

関連する各種資料

Manufacturing Process Scale-up for Phase III: Clear Sailing or Storms Ahead?

Getting from R&D to IND - Pitfalls to avoid and how to succeed

Fixed dose combination drug development: Designing a lifecycle strategy with agility & speed

Manufacturing Innovation: The Case for Continuous Manufacturing

Navigating Decision Points to Fast-Track Commercialisation

Sterile formulation strategies to shorten timelines for first-in-human studies

Steriles Drug Development & Manufacturing: Flexibility and Optimization

Orphan Drugs: Balancing Financial Incentives & Complex Challenges

mysupply Platform: An End-to-End Digital Supply Chain Platform

Navigating the Adoption of Continuous Manufacturing Amid Unprecedented Global Challenges

Impact of a Pandemic Outbreak on Vaccine Development Approach

Vaccine Development: Strategic Approach & Response During Pandemics

Lyophilization: Small-Large Scale Comparability

A Quality by Design Approach to Optimize Tablet Formulations containing PVP VA64 Amorphous Dispersions: Formulation Variables

Discrete Element Modeling of a Pharmaceutical Blending Process

Evaluation of a Quality by Design (QbD) Approach for Process Development and Scale-Up of a Novel ALS Drug Product

Enhanced Solubilization of an Analgesic/Antipyretic Drug With The Use of Polymeric Excipients

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral/Injectable Delivery

Addressing Technical Challenges in Development Drug Products: A CDMO Perspective

Technology Transfers Best Practices for Optimizing Success and Mitigating Risk

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Early Development Fact Sheet

Continuous Manufacturing: The Alternative to Batch Manufacturing

Infographic: A Tale of Two Molecules

Telltale Signs You're with the Wrong CDMO

Strategies for API Solubility and Bioavailability Enhancement

Rise in Targeted Therapies Drives Need for Small-Volume Manufacturing

Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

Biologics Overview: Flexible Biomanufacturing Solutions

Technology Transfers: Reaping Rewards, Reducing Risks